<!DOCTYPE html>
<html lang="ja">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>å‰µè–¬ã¨ãƒãƒ†ãƒªã‚¢ãƒ«ã‚ºãƒ»ã‚¤ãƒ³ãƒ•ã‚©ãƒãƒ†ã‚£ã‚¯ã‚¹ã®å½¹å‰² - AI Terakoya</title>

    <style>
        :root {
            --color-primary: #2c3e50;
            --color-primary-dark: #1a252f;
            --color-accent: #7b2cbf;
            --color-accent-light: #9d4edd;
            --color-text: #2d3748;
            --color-text-light: #4a5568;
            --color-bg: #ffffff;
            --color-bg-alt: #f7fafc;
            --color-border: #e2e8f0;
            --color-code-bg: #f8f9fa;
            --color-link: #3182ce;
            --color-link-hover: #2c5aa0;

            --spacing-xs: 0.5rem;
            --spacing-sm: 1rem;
            --spacing-md: 1.5rem;
            --spacing-lg: 2rem;
            --spacing-xl: 3rem;

            --font-body: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            --font-mono: "SFMono-Regular", Consolas, "Liberation Mono", Menlo, monospace;

            --border-radius: 8px;
            --box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1);
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: var(--font-body);
            line-height: 1.7;
            color: var(--color-text);
            background-color: var(--color-bg);
            font-size: 16px;
        }

        header {
            background: linear-gradient(135deg, var(--color-accent) 0%, var(--color-accent-light) 100%);
            color: white;
            padding: var(--spacing-xl) var(--spacing-md);
            margin-bottom: var(--spacing-xl);
            box-shadow: var(--box-shadow);
        }

        .header-content {
            max-width: 900px;
            margin: 0 auto;
        }

        h1 {
            font-size: 2rem;
            font-weight: 700;
            margin-bottom: var(--spacing-sm);
            line-height: 1.2;
        }

        .subtitle {
            font-size: 1.1rem;
            opacity: 0.95;
            font-weight: 400;
            margin-bottom: var(--spacing-md);
        }

        .meta {
            display: flex;
            flex-wrap: wrap;
            gap: var(--spacing-md);
            font-size: 0.9rem;
            opacity: 0.9;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 0.3rem;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            padding: 0 var(--spacing-md) var(--spacing-xl);
        }

        h2 {
            font-size: 1.75rem;
            color: var(--color-primary);
            margin-top: var(--spacing-xl);
            margin-bottom: var(--spacing-md);
            padding-bottom: var(--spacing-xs);
            border-bottom: 3px solid var(--color-accent);
        }

        h3 {
            font-size: 1.4rem;
            color: var(--color-primary);
            margin-top: var(--spacing-lg);
            margin-bottom: var(--spacing-sm);
        }

        h4 {
            font-size: 1.1rem;
            color: var(--color-primary-dark);
            margin-top: var(--spacing-md);
            margin-bottom: var(--spacing-sm);
        }

        p {
            margin-bottom: var(--spacing-md);
            color: var(--color-text);
        }

        a {
            color: var(--color-link);
            text-decoration: none;
            transition: color 0.2s;
        }

        a:hover {
            color: var(--color-link-hover);
            text-decoration: underline;
        }

        ul, ol {
            margin-left: var(--spacing-lg);
            margin-bottom: var(--spacing-md);
        }

        li {
            margin-bottom: var(--spacing-xs);
            color: var(--color-text);
        }

        pre {
            background-color: var(--color-code-bg);
            border: 1px solid var(--color-border);
            border-radius: var(--border-radius);
            padding: var(--spacing-md);
            overflow-x: auto;
            margin-bottom: var(--spacing-md);
            font-family: var(--font-mono);
            font-size: 0.9rem;
            line-height: 1.5;
        }

        code {
            font-family: var(--font-mono);
            font-size: 0.9em;
            background-color: var(--color-code-bg);
            padding: 0.2em 0.4em;
            border-radius: 3px;
        }

        pre code {
            background-color: transparent;
            padding: 0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin-bottom: var(--spacing-md);
            font-size: 0.95rem;
        }

        th, td {
            border: 1px solid var(--color-border);
            padding: var(--spacing-sm);
            text-align: left;
        }

        th {
            background-color: var(--color-bg-alt);
            font-weight: 600;
            color: var(--color-primary);
        }

        blockquote {
            border-left: 4px solid var(--color-accent);
            padding-left: var(--spacing-md);
            margin: var(--spacing-md) 0;
            color: var(--color-text-light);
            font-style: italic;
            background-color: var(--color-bg-alt);
            padding: var(--spacing-md);
            border-radius: var(--border-radius);
        }

        .mermaid {
            text-align: center;
            margin: var(--spacing-lg) 0;
            background-color: var(--color-bg-alt);
            padding: var(--spacing-md);
            border-radius: var(--border-radius);
        }

        details {
            background-color: var(--color-bg-alt);
            border: 1px solid var(--color-border);
            border-radius: var(--border-radius);
            padding: var(--spacing-md);
            margin-bottom: var(--spacing-md);
        }

        summary {
            cursor: pointer;
            font-weight: 600;
            color: var(--color-primary);
            user-select: none;
            padding: var(--spacing-xs);
            margin: calc(-1 * var(--spacing-md));
            padding: var(--spacing-md);
            border-radius: var(--border-radius);
        }

        summary:hover {
            background-color: rgba(123, 44, 191, 0.1);
        }

        details[open] summary {
            margin-bottom: var(--spacing-md);
            border-bottom: 1px solid var(--color-border);
        }

        .navigation {
            display: flex;
            justify-content: space-between;
            gap: var(--spacing-md);
            margin: var(--spacing-xl) 0;
            padding-top: var(--spacing-lg);
            border-top: 2px solid var(--color-border);
        }

        .nav-button {
            flex: 1;
            padding: var(--spacing-md);
            background: linear-gradient(135deg, var(--color-accent) 0%, var(--color-accent-light) 100%);
            color: white;
            border-radius: var(--border-radius);
            text-align: center;
            font-weight: 600;
            transition: transform 0.2s, box-shadow 0.2s;
            box-shadow: var(--box-shadow);
        }

        .nav-button:hover {
            transform: translateY(-2px);
            box-shadow: 0 4px 12px rgba(0, 0, 0, 0.15);
            text-decoration: none;
        }

        footer {
            margin-top: var(--spacing-xl);
            padding: var(--spacing-lg) var(--spacing-md);
            background-color: var(--color-bg-alt);
            border-top: 1px solid var(--color-border);
            text-align: center;
            font-size: 0.9rem;
            color: var(--color-text-light);
        }
        .disclaimer {
            max-width: 900px;
            margin: 2rem auto;
            padding: 1.5rem;
            background: #f8f9fa;
            border-left: 4px solid #6c757d;
            border-radius: 4px;
        }

        .disclaimer h3 {
            color: #495057;
            margin-bottom: 1rem;
            font-size: 1.1rem;
        }

        .disclaimer ul {
            list-style: none;
            padding-left: 0;
        }

        .disclaimer li {
            padding: 0.5rem 0;
            padding-left: 1.5rem;
            position: relative;
            font-size: 0.9rem;
            color: #6c757d;
            line-height: 1.6;
        }

        .disclaimer li::before {
            content: "âš ï¸";
            position: absolute;
            left: 0;
        }


        @media (max-width: 768px) {
            h1 { font-size: 1.5rem; }
            h2 { font-size: 1.4rem; }
            h3 { font-size: 1.2rem; }
            .meta { font-size: 0.85rem; }
            .navigation { flex-direction: column; }
            table { font-size: 0.85rem; }
            th, td { padding: var(--spacing-xs); }
        }
    
        
    
        /* Breadcrumb styles */
        .breadcrumb {
            background: #f7fafc;
            padding: 0.75rem 1rem;
            border-bottom: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .breadcrumb-content {
            max-width: 900px;
            margin: 0 auto;
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 0.5rem;
        }

        .breadcrumb a {
            color: #667eea;
            text-decoration: none;
            transition: color 0.2s;
        }

        .breadcrumb a:hover {
            color: #764ba2;
            text-decoration: underline;
        }

        .breadcrumb-separator {
            color: #a0aec0;
            margin: 0 0.25rem;
        }

        .breadcrumb-current {
            color: #4a5568;
            font-weight: 500;
        }
    </style>

    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({ startOnLoad: true, theme: 'default', securityLevel: 'strict' });
    </script>

    <script>
        MathJax = {
            tex: {
                inlineMath: [['$', '$'], ['\(', '\)']],
                displayMath: [['$$', '$$'], ['\[', '\]']],
                processEscapes: true
            }
        };
    </script>
    <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js" async></script>

    <style>
        /* Locale Switcher Styles */
        .locale-switcher {
            display: flex;
            align-items: center;
            gap: 0.5rem;
            padding: 0.5rem 1rem;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-radius: 6px;
            font-size: 0.9rem;
            margin-bottom: 1rem;
            box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
        }

        .current-locale {
            font-weight: 600;
            color: #7b2cbf;
            display: flex;
            align-items: center;
            gap: 0.25rem;
        }

        .locale-separator {
            color: #adb5bd;
            font-weight: 300;
        }

        .locale-link {
            color: #f093fb;
            text-decoration: none;
            font-weight: 500;
            transition: all 0.2s ease;
            display: flex;
            align-items: center;
            gap: 0.25rem;
            padding: 0.2rem 0.5rem;
            border-radius: 4px;
        }

        .locale-link:hover {
            background: rgba(240, 147, 251, 0.1);
            color: #d07be8;
            transform: translateY(-1px);
        }

        .locale-meta {
            color: #868e96;
            font-size: 0.85rem;
            font-style: italic;
            margin-left: auto;
        }

        @media (max-width: 768px) {
            .locale-switcher {
                font-size: 0.85rem;
                padding: 0.4rem 0.8rem;
            }
            .locale-meta {
                display: none;
            }
        }
    </style>
</head>
<body>
            <div class="locale-switcher">
<span class="current-locale">ğŸŒ JP</span>
<span class="locale-separator">|</span>
<a href="../../../en/MI/drug-discovery-mi-application/chapter1-background.html" class="locale-link">ğŸ‡¬ğŸ‡§ EN</a>
<span class="locale-separator">|</span>
<span class="locale-meta">Last sync: 2025-11-16</span>
</div>
<nav class="breadcrumb">
        <div class="breadcrumb-content">
            <a href="../../index.html">AIå¯ºå­å±‹ãƒˆãƒƒãƒ—</a><span class="breadcrumb-separator">â€º</span><a href="../../MI/index.html">ãƒãƒ†ãƒªã‚¢ãƒ«ã‚ºãƒ»ã‚¤ãƒ³ãƒ•ã‚©ãƒãƒ†ã‚£ã‚¯ã‚¹</a><span class="breadcrumb-separator">â€º</span><a href="../../MI/drug-discovery-mi-application/index.html">Drug Discovery Mi Application</a><span class="breadcrumb-separator">â€º</span><span class="breadcrumb-current">Chapter 1</span>
        </div>
    </nav>

        <header>
        <div class="header-content">
            <h1>å‰µè–¬ã¨ãƒãƒ†ãƒªã‚¢ãƒ«ã‚ºãƒ»ã‚¤ãƒ³ãƒ•ã‚©ãƒãƒ†ã‚£ã‚¯ã‚¹ã®å½¹å‰²</h1>
            <p class="subtitle">åŒ»è–¬å“é–‹ç™ºã¨AIé§†å‹•å‰µè–¬ã®åŸºç¤</p>
            <div class="meta">
                <span class="meta-item">ğŸ“– 30-35åˆ†</span>
                <span class="meta-item">ğŸ“Š åˆç´š</span>
                <span class="meta-item">ğŸ’» 0å€‹</span>
                <span class="meta-item">ğŸ“ 5å•</span>
            </div>
        </div>
    </header>

    <main class="container">
<h1>ç¬¬1ç« ï¼šå‰µè–¬ã«ãŠã‘ã‚‹ãƒãƒ†ãƒªã‚¢ãƒ«ã‚ºãƒ»ã‚¤ãƒ³ãƒ•ã‚©ãƒãƒ†ã‚£ã‚¯ã‚¹ã®å½¹å‰²</h1>
<p><strong>å‰µè–¬ãƒ—ãƒ­ã‚»ã‚¹ã®å¤‰é© - ä¼çµ±ã‹ã‚‰é©æ–°ã¸</strong></p>
<h2>1.1 å‰µè–¬ãƒ—ãƒ­ã‚»ã‚¹ã®ç¾çŠ¶ã¨èª²é¡Œ</h2>
<h3>1.1.1 å¾“æ¥ã®å‰µè–¬ãƒ—ãƒ­ã‚»ã‚¹</h3>
<p>æ–°è–¬ã®é–‹ç™ºã¯ã€äººé¡ã®å¥åº·ã‚’å®ˆã‚‹æœ€ã‚‚é‡è¦ãªç§‘å­¦çš„æŒ‘æˆ¦ã®ä¸€ã¤ã§ã™ã€‚ã—ã‹ã—ã€ãã®é“ã®ã‚Šã¯é©šãã»ã©é•·ãã€å›°é›£ã§ã€ã‚³ã‚¹ãƒˆãŒã‹ã‹ã‚Šã¾ã™ã€‚</p>
<p><strong>å…¸å‹çš„ãªå‰µè–¬ã‚¿ã‚¤ãƒ ãƒ©ã‚¤ãƒ³:</strong></p>
<div class="mermaid">
flowchart LR
    A[ã‚¿ãƒ¼ã‚²ãƒƒãƒˆåŒå®š\n1-2å¹´] --> B[ãƒªãƒ¼ãƒ‰åŒ–åˆç‰©ç™ºè¦‹\n2-3å¹´]
    B --> C[ãƒªãƒ¼ãƒ‰æœ€é©åŒ–\n2-3å¹´]
    C --> D[å‰è‡¨åºŠè©¦é¨“\n1-2å¹´]
    D --> E[Phase I\n1-2å¹´]
    E --> F[Phase II\n2-3å¹´]
    F --> G[Phase III\n2-4å¹´]
    G --> H[FDAæ‰¿èª\n1-2å¹´]

    style A fill:#ffebee
    style B fill:#fff3e0
    style C fill:#e3f2fd
    style D fill:#f3e5f5
    style E fill:#e8f5e9
    style F fill:#fff9c4
    style G fill:#fce4ec
    style H fill:#e0f2f1
</div>

<p><strong>ç¾å®Ÿã®æ•°å­—:</strong>
- <strong>é–‹ç™ºæœŸé–“</strong>: 10-15å¹´ï¼ˆå¹³å‡12å¹´ï¼‰
- <strong>æˆåŠŸç‡</strong>: 0.01%ï¼ˆ10,000åŒ–åˆç‰©ã‹ã‚‰1ã¤ã®æ‰¿èªè–¬ï¼‰
- <strong>ç·ã‚³ã‚¹ãƒˆ</strong>: $2.6Bï¼ˆç´„2,600å„„å††ï¼‰
- <strong>å¹´é–“æ‰¿èªè–¬</strong>: ç´„50å€‹ï¼ˆFDAã€2020-2023å¹´å¹³å‡ï¼‰</p>
<h3>1.1.2 å‰µè–¬ã®5ã¤ã®ã‚¹ãƒ†ãƒ¼ã‚¸</h3>
<h4>Stage 1: ã‚¿ãƒ¼ã‚²ãƒƒãƒˆåŒå®šï¼ˆTarget Identificationï¼‰</h4>
<p><strong>ç›®çš„</strong>: ç–¾æ‚£ã«é–¢ä¸ã™ã‚‹ã‚¿ãƒ³ãƒ‘ã‚¯è³ªãƒ»éºä¼å­ã‚’ç‰¹å®š</p>
<p><strong>æ‰‹æ³•</strong>:
- ã‚²ãƒãƒŸã‚¯ã‚¹è§£æï¼ˆGWAS: Genome-Wide Association Studiesï¼‰
- ãƒ—ãƒ­ãƒ†ã‚ªãƒŸã‚¯ã‚¹ï¼ˆã‚¿ãƒ³ãƒ‘ã‚¯è³ªç™ºç¾ãƒ—ãƒ­ãƒ•ã‚¡ã‚¤ãƒªãƒ³ã‚°ï¼‰
- ãƒã‚¤ã‚ªã‚¤ãƒ³ãƒ•ã‚©ãƒãƒ†ã‚£ã‚¯ã‚¹ï¼ˆãƒ‘ã‚¹ã‚¦ã‚§ã‚¤è§£æï¼‰</p>
<p><strong>èª²é¡Œ</strong>:
- ã‚¿ãƒ¼ã‚²ãƒƒãƒˆã®å¦¥å½“æ€§æ¤œè¨¼ãŒå›°é›£
- ç–¾æ‚£ãƒ¡ã‚«ãƒ‹ã‚ºãƒ ã®è¤‡é›‘æ€§ï¼ˆãƒãƒ«ãƒãƒ•ã‚¡ã‚¯ã‚¿ãƒ¼ï¼‰
- False positiveï¼ˆå½é™½æ€§ï¼‰ã®å¤šã•</p>
<p><strong>ä¾‹</strong>: ã‚¢ãƒ«ãƒ„ãƒã‚¤ãƒãƒ¼ç—…ã®ã‚¿ãƒ¼ã‚²ãƒƒãƒˆ
- ã‚¢ãƒŸãƒ­ã‚¤ãƒ‰Î²ï¼ˆAÎ²ï¼‰è“„ç©
- Tau proteinç•°å¸¸ãƒªãƒ³é…¸åŒ–
- APOE4éºä¼å­å¤‰ç•°
- ç¥çµŒç‚ç—‡ï¼ˆIL-1Î², TNF-Î±ï¼‰</p>
<h4>Stage 2: ãƒªãƒ¼ãƒ‰åŒ–åˆç‰©ç™ºè¦‹ï¼ˆLead Discoveryï¼‰</h4>
<p><strong>ç›®çš„</strong>: ã‚¿ãƒ¼ã‚²ãƒƒãƒˆã«çµåˆã—ã€æ´»æ€§ã‚’ç¤ºã™åŒ–åˆç‰©ã‚’è¦‹ã¤ã‘ã‚‹</p>
<p><strong>æ‰‹æ³•</strong>:
- <strong>ãƒã‚¤ã‚¹ãƒ«ãƒ¼ãƒ—ãƒƒãƒˆã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ï¼ˆHTSï¼‰</strong>: æ•°åä¸‡ã€œæ•°ç™¾ä¸‡åŒ–åˆç‰©ã‚’è‡ªå‹•è©•ä¾¡
- <strong>Fragment-based Drug Discoveryï¼ˆFBDDï¼‰</strong>: å°ã•ãªåˆ†å­æ–­ç‰‡ã‹ã‚‰é–‹å§‹
- <strong>Virtual Screeningï¼ˆVSï¼‰</strong>: è¨ˆç®—åŒ–å­¦ã«ã‚ˆã‚‹å€™è£œåŒ–åˆç‰©é¸å®š</p>
<p><strong>èª²é¡Œ</strong>:
- ãƒ’ãƒƒãƒˆåŒ–åˆç‰©ã®æ´»æ€§ãŒä½ã„ï¼ˆé€šå¸¸IC50 &gt; 10 Î¼Mï¼‰
- å½é™½æ€§ï¼ˆã‚¢ãƒƒã‚»ã‚¤æ¡ä»¶ä¾å­˜ã®æ´»æ€§ï¼‰
- ç‰¹è¨±å•é¡Œï¼ˆæ—¢å­˜åŒ–åˆç‰©ã¨ã®é¡ä¼¼æ€§ï¼‰</p>
<p><strong>çµ±è¨ˆ</strong>:
- HTSãƒ’ãƒƒãƒˆç‡: 0.01-0.1%ï¼ˆ1,000,000åŒ–åˆç‰© â†’ 100-1,000ãƒ’ãƒƒãƒˆï¼‰
- ãƒªãƒ¼ãƒ‰åŒ–åˆç‰©ã¸ã®é€²è¡Œ: ãƒ’ãƒƒãƒˆã®1-5%ï¼ˆ100ãƒ’ãƒƒãƒˆ â†’ 1-5ãƒªãƒ¼ãƒ‰ï¼‰</p>
<h4>Stage 3: ãƒªãƒ¼ãƒ‰æœ€é©åŒ–ï¼ˆLead Optimizationï¼‰</h4>
<p><strong>ç›®çš„</strong>: ãƒªãƒ¼ãƒ‰åŒ–åˆç‰©ã®æ´»æ€§ãƒ»é¸æŠæ€§ãƒ»ADMETç‰¹æ€§ã‚’æ”¹å–„</p>
<p><strong>æœ€é©åŒ–ãƒ‘ãƒ©ãƒ¡ãƒ¼ã‚¿</strong>:
1. <strong>Potencyï¼ˆæ´»æ€§ï¼‰</strong>: IC50 &lt; 100 nMç›®æ¨™
2. <strong>Selectivityï¼ˆé¸æŠæ€§ï¼‰</strong>: ã‚ªãƒ•ã‚¿ãƒ¼ã‚²ãƒƒãƒˆåŠ¹æœã‚’æœ€å°åŒ–
3. <strong>ADMETç‰¹æ€§</strong>:
   - <strong>A</strong>bsorption: çµŒå£å¸åæ€§ï¼ˆCaco-2 &gt; 10^-6 cm/sï¼‰
   - <strong>D</strong>istribution: çµ„ç¹”åˆ†å¸ƒã€BBBé€éæ€§
   - <strong>M</strong>etabolism: ä»£è¬å®‰å®šæ€§ï¼ˆè‚ãƒŸã‚¯ãƒ­ã‚½ãƒ¼ãƒ ï¼‰
   - <strong>E</strong>xcretion: è…ã‚¯ãƒªã‚¢ãƒ©ãƒ³ã‚¹
   - <strong>T</strong>oxicity: è‚æ¯’æ€§ã€å¿ƒæ¯’æ€§ï¼ˆhERGé˜»å®³ï¼‰</p>
<p><strong>èª²é¡Œ</strong>:
- å¤šç›®çš„æœ€é©åŒ–ï¼ˆæ´»æ€§ vs æ¯’æ€§ã®ãƒˆãƒ¬ãƒ¼ãƒ‰ã‚ªãƒ•ï¼‰
- æ§‹é€ æ´»æ€§ç›¸é–¢ï¼ˆSARï¼‰ã®è§£æ˜ãŒæ™‚é–“ã‹ã‹ã‚‹
- åˆæˆã®é›£ã—ã•ï¼ˆè¤‡é›‘ãªåŒ–å­¦æ§‹é€ ï¼‰</p>
<p><strong>ä¾‹</strong>: Lipitorï¼ˆã‚¢ãƒˆãƒ«ãƒã‚¹ã‚¿ãƒãƒ³ã€ã‚³ãƒ¬ã‚¹ãƒ†ãƒ­ãƒ¼ãƒ«ä½ä¸‹è–¬ï¼‰
- åˆæœŸãƒªãƒ¼ãƒ‰: IC50 = 50 nM
- æœ€é©åŒ–å¾Œ: IC50 = 2 nMï¼ˆ25å€æ”¹å–„ï¼‰
- é–‹ç™ºæœŸé–“: 5å¹´ã€åˆæˆåŒ–åˆç‰©æ•°: 1,000+</p>
<h4>Stage 4: å‰è‡¨åºŠè©¦é¨“ï¼ˆPreclinical Studiesï¼‰</h4>
<p><strong>ç›®çš„</strong>: å‹•ç‰©å®Ÿé¨“ã§å®‰å…¨æ€§ãƒ»æœ‰åŠ¹æ€§ã‚’æ¤œè¨¼</p>
<p><strong>å®Ÿæ–½é …ç›®</strong>:
- <strong>In vivoè–¬åŠ¹è©¦é¨“</strong>: ãƒã‚¦ã‚¹ãƒ»ãƒ©ãƒƒãƒˆç–¾æ‚£ãƒ¢ãƒ‡ãƒ«
- <strong>æ¯’æ€§è©¦é¨“</strong>: æ€¥æ€§æ¯’æ€§ã€äºœæ€¥æ€§æ¯’æ€§ã€æ…¢æ€§æ¯’æ€§
- <strong>è–¬ç‰©å‹•æ…‹ï¼ˆPKï¼‰</strong>: è¡€ä¸­æ¿ƒåº¦æ¨ç§»ã€åŠæ¸›æœŸ
- <strong>è–¬åŠ›å­¦ï¼ˆPDï¼‰</strong>: è–¬ç†ä½œç”¨ã®ãƒ¡ã‚«ãƒ‹ã‚ºãƒ </p>
<p><strong>è¦åˆ¶è¦ä»¶</strong>:
- GLPï¼ˆGood Laboratory Practiceï¼‰æº–æ‹ 
- 2ç¨®ä»¥ä¸Šã®å‹•ç‰©ç¨®ã§ã®è©¦é¨“
- ç™ºãŒã‚“æ€§è©¦é¨“ï¼ˆæ…¢æ€§ç–¾æ‚£æ²»ç™‚è–¬ã®å ´åˆï¼‰</p>
<p><strong>å¤±æ•—ç‡</strong>: 90%ï¼ˆå‰è‡¨åºŠã§10åŒ–åˆç‰© â†’ 1åŒ–åˆç‰©ãŒè‡¨åºŠã¸ï¼‰</p>
<h4>Stage 5: è‡¨åºŠè©¦é¨“ï¼ˆClinical Trialsï¼‰</h4>
<p><strong>Phase I</strong>: å¥åº·ãªãƒœãƒ©ãƒ³ãƒ†ã‚£ã‚¢ï¼ˆ20-100äººï¼‰
- ç›®çš„: å®‰å…¨æ€§ã€ç”¨é‡æ±ºå®š
- æœŸé–“: 1-2å¹´
- æˆåŠŸç‡: 70%</p>
<p><strong>Phase II</strong>: æ‚£è€…ï¼ˆ100-500äººï¼‰
- ç›®çš„: æœ‰åŠ¹æ€§ã®åˆæœŸè©•ä¾¡ã€å‰¯ä½œç”¨ç¢ºèª
- æœŸé–“: 2-3å¹´
- æˆåŠŸç‡: 33%</p>
<p><strong>Phase III</strong>: æ‚£è€…ï¼ˆ1,000-5,000äººï¼‰
- ç›®çš„: å¤§è¦æ¨¡æœ‰åŠ¹æ€§ãƒ»å®‰å…¨æ€§æ¤œè¨¼
- æœŸé–“: 2-4å¹´
- æˆåŠŸç‡: 25-30%</p>
<p><strong>FDAæ‰¿èª</strong>: 1-2å¹´
- ç”³è«‹æ›¸ï¼ˆNDA: New Drug Applicationï¼‰: 10ä¸‡ãƒšãƒ¼ã‚¸ä»¥ä¸Š
- å¯©æŸ»è²»ç”¨: $2-3M
- æ‰¿èªç‡: 85%ï¼ˆPhase IIIã‚¯ãƒªã‚¢å¾Œï¼‰</p>
<h3>1.1.3 å¾“æ¥å‰µè–¬ã®3ã¤ã®é™ç•Œ</h3>
<h4>é™ç•Œ1: è†¨å¤§ãªæ™‚é–“ã¨ã‚³ã‚¹ãƒˆ</h4>
<p><strong>æ™‚é–“ã®å•é¡Œ</strong>:
- å¹³å‡12å¹´ï¼ˆã‚¿ãƒ¼ã‚²ãƒƒãƒˆåŒå®š â†’ FDAæ‰¿èªï¼‰
- ãŒã‚“æ‚£è€…ã®5å¹´ç”Ÿå­˜ç‡æ”¹å–„ã«ã¯é–“ã«åˆã‚ãªã„
- ãƒ‘ãƒ³ãƒ‡ãƒŸãƒƒã‚¯å¯¾å¿œã«ã¯é…ã™ãã‚‹ï¼ˆCOVID-19: ãƒ¯ã‚¯ãƒãƒ³é–‹ç™º1å¹´ï¼‰</p>
<p><strong>ã‚³ã‚¹ãƒˆã®å•é¡Œ</strong>:
- $2.6B/è–¬ï¼ˆ2020å¹´æ¨å®šã€Tufts Centerèª¿æŸ»ï¼‰
- å†…è¨³:
  - å‰è‡¨åºŠ: $500M
  - è‡¨åºŠè©¦é¨“: $1.4B
  - å¤±æ•—ã‚³ã‚¹ãƒˆ: $700Mï¼ˆéå»ã®å¤±æ•—ãƒ—ãƒ­ã‚¸ã‚§ã‚¯ãƒˆã®å„Ÿå´ï¼‰</p>
<p><strong>çµŒæ¸ˆçš„å½±éŸ¿</strong>:
- è–¬ä¾¡é«˜é¨°ï¼ˆé–‹ç™ºã‚³ã‚¹ãƒˆå›åã®ãŸã‚ï¼‰
- ã‚ªãƒ¼ãƒ•ã‚¡ãƒ³ãƒ‰ãƒ©ãƒƒã‚°ï¼ˆå¸Œå°‘ç–¾æ‚£æ²»ç™‚è–¬ï¼‰ã®é–‹ç™ºåœæ»
- ã‚¸ã‚§ãƒãƒªãƒƒã‚¯åŒ»è–¬å“ã¸ã®ä¾å­˜</p>
<h4>é™ç•Œ2: ä½ã„æˆåŠŸç‡</h4>
<p><strong>åŒ–åˆç‰©ã®æ¸›å°‘ç‡</strong>:</p>
<div class="mermaid">
flowchart TD
    A[ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°\n1,000,000åŒ–åˆç‰©] -->|0.01%| B[ãƒ’ãƒƒãƒˆ\n1,000åŒ–åˆç‰©]
    B -->|5%| C[ãƒªãƒ¼ãƒ‰\n50åŒ–åˆç‰©]
    C -->|20%| D[å‰è‡¨åºŠ\n10åŒ–åˆç‰©]
    D -->|10%| E[Phase I\n1åŒ–åˆç‰©]
    E -->|70%| F[Phase II\n0.7åŒ–åˆç‰©]
    F -->|33%| G[Phase III\n0.23åŒ–åˆç‰©]
    G -->|25%| H[FDAæ‰¿èª\n0.06åŒ–åˆç‰©]

    style A fill:#ffebee
    style H fill:#e8f5e9
</div>

<p><strong>æœ€çµ‚æˆåŠŸç‡</strong>: 0.00006%ï¼ˆ100ä¸‡ â†’ 0.06ï¼‰</p>
<p><strong>å¤±æ•—ã®ä¸»è¦åŸå› </strong>:
1. <strong>æœ‰åŠ¹æ€§ä¸è¶³</strong>ï¼ˆ40%ï¼‰: Phase II/IIIã§æœŸå¾…ã—ãŸåŠ¹æœãªã—
2. <strong>æ¯’æ€§å•é¡Œ</strong>ï¼ˆ30%ï¼‰: è‚æ¯’æ€§ã€å¿ƒæ¯’æ€§ã€ç™ºãŒã‚“æ€§
3. <strong>PK/PDä¸è‰¯</strong>ï¼ˆ20%ï¼‰: è–¬ç‰©å‹•æ…‹ãŒä¸é©åˆ‡ã€çµ„ç¹”åˆ°é”æ€§ä½ã„
4. <strong>å•†æ¥­çš„ç†ç”±</strong>ï¼ˆ10%ï¼‰: å¸‚å ´æ€§åˆ¤æ–­ã€ç‰¹è¨±å•é¡Œ</p>
<h4>é™ç•Œ3: åŒ–å­¦ç©ºé–“ã®æ¢ç´¢ä¸è¶³</h4>
<p><strong>åŒ–å­¦ç©ºé–“ã®åºƒå¤§ã•</strong>:
- è–¬ç‰©æ§˜åŒ–å­¦ç©ºé–“: 10^60åˆ†å­ï¼ˆæ¨å®šï¼‰
- æ—¢çŸ¥åŒ–åˆç‰©: 10^8åˆ†å­ï¼ˆPubChemï¼‰
- æ¢ç´¢æ¸ˆã¿: 0.0000000000000000000000000000000000000000000001%</p>
<p><strong>HTSã®é™ç•Œ</strong>:
- ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°å¯èƒ½: 10^6åˆ†å­/ã‚­ãƒ£ãƒ³ãƒšãƒ¼ãƒ³
- åŒ–åˆç‰©ãƒ©ã‚¤ãƒ–ãƒ©ãƒªã®ãƒã‚¤ã‚¢ã‚¹ï¼ˆåˆæˆã—ã‚„ã™ã„åˆ†å­ã«åã‚Šï¼‰
- "Low-hanging fruit problem"ï¼ˆç°¡å˜ãªåŒ–åˆç‰©ã¯æ—¢ã«ç™ºè¦‹æ¸ˆã¿ï¼‰</p>
<p><strong>ä¾‹</strong>: ã‚­ãƒŠãƒ¼ã‚¼é˜»å®³å‰¤
- ãƒ’ãƒˆã‚­ãƒŠãƒ¼ã‚¼: 518ç¨®é¡
- æ‰¿èªè–¬: 70å€‹ï¼ˆ2023å¹´ï¼‰
- æœªæ¢ç´¢ã‚­ãƒŠãƒ¼ã‚¼: 85%ä»¥ä¸Š</p>
<hr />
<h2>1.2 MIãŒè§£æ±ºã™ã‚‹3ã¤ã®èª²é¡Œ</h2>
<p>ãƒãƒ†ãƒªã‚¢ãƒ«ã‚ºãƒ»ã‚¤ãƒ³ãƒ•ã‚©ãƒãƒ†ã‚£ã‚¯ã‚¹ï¼ˆMIï¼‰ã¨AI/æ©Ÿæ¢°å­¦ç¿’ã®çµ±åˆã«ã‚ˆã‚Šã€å¾“æ¥å‰µè–¬ã®é™ç•Œã‚’æ‰“ç ´ã§ãã¾ã™ã€‚</p>
<h3>1.2.1 èª²é¡Œ1: è†¨å¤§ãªåŒ–å­¦ç©ºé–“ã‹ã‚‰ã®åŠ¹ç‡çš„æ¢ç´¢</h3>
<h4>å¾“æ¥æ‰‹æ³•ã®å•é¡Œç‚¹</h4>
<p><strong>ãƒ©ãƒ³ãƒ€ãƒ ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°</strong>:
- æ¢ç´¢: ãƒ©ãƒ³ãƒ€ãƒ ã¾ãŸã¯ãƒ«ãƒ¼ãƒ«ãƒ™ãƒ¼ã‚¹ï¼ˆLipinski's Rule of Fiveï¼‰
- åŠ¹ç‡: ä½ã„ï¼ˆãƒ’ãƒƒãƒˆç‡0.01-0.1%ï¼‰
- ãƒã‚¤ã‚¢ã‚¹: åˆæˆå¯èƒ½ãªåˆ†å­ã«é™å®š</p>
<p><strong>åŒ–å­¦è€…ã®ç›´æ„Ÿ</strong>:
- çµŒé¨“å‰‡: éå»ã®æˆåŠŸä¾‹ã«åŸºã¥ã
- å•é¡Œ: æ–°è¦éª¨æ ¼ã®ç™ºè¦‹ãŒå›°é›£ã€ãƒã‚¤ã‚¢ã‚¹ãŒå¼·ã„
- ã‚¹ã‚±ãƒ¼ãƒ«: å¹´é–“100-1,000åŒ–åˆç‰©ç¨‹åº¦</p>
<h4>MIã‚¢ãƒ—ãƒ­ãƒ¼ãƒ</h4>
<p><strong>Virtual Screeningï¼ˆãƒãƒ¼ãƒãƒ£ãƒ«ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ï¼‰</strong>:</p>
<pre><code class="language-python"># ä¾‹: 10å„„åŒ–åˆç‰©ã‚’1æ—¥ã§ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°
from rdkit import Chem
from rdkit.Chem import Descriptors
import pandas as pd

# åŒ–åˆç‰©ãƒ©ã‚¤ãƒ–ãƒ©ãƒªï¼ˆSMILESå½¢å¼ï¼‰
compounds = pd.read_csv('billion_compounds.csv')  # 10^9è¡Œ

# è–¬ç‰©æ§˜ãƒ•ã‚£ãƒ«ã‚¿ãƒ¼ï¼ˆLipinski's Rule of Fiveï¼‰
def lipinski_filter(smiles):
    mol = Chem.MolFromSmiles(smiles)
    if mol is None:
        return False
    mw = Descriptors.MolWt(mol)
    logp = Descriptors.MolLogP(mol)
    hbd = Descriptors.NumHDonors(mol)
    hba = Descriptors.NumHAcceptors(mol)

    return (mw &lt;= 500 and logp &lt;= 5 and hbd &lt;= 5 and hba &lt;= 10)

# ä¸¦åˆ—å‡¦ç†ã§é«˜é€Ÿãƒ•ã‚£ãƒ«ã‚¿ãƒªãƒ³ã‚°ï¼ˆ1æ—¥ã§å®Œäº†ï¼‰
filtered = compounds[compounds['smiles'].apply(lipinski_filter)]
# 10^9 â†’ 10^7åŒ–åˆç‰©ï¼ˆ100å€å‰Šæ¸›ï¼‰
</code></pre>
<p><strong>æ©Ÿæ¢°å­¦ç¿’äºˆæ¸¬ãƒ¢ãƒ‡ãƒ«</strong>:
- è¨“ç·´: æ—¢çŸ¥ã®æ´»æ€§åŒ–åˆç‰©ãƒ‡ãƒ¼ã‚¿ï¼ˆChEMBL: 200ä¸‡åŒ–åˆç‰©ï¼‰
- äºˆæ¸¬: 10^9åŒ–åˆç‰©ã®æ´»æ€§ã‚’æ•°æ™‚é–“ã§äºˆæ¸¬
- æ¿ƒç¸®ç‡: ãƒ’ãƒƒãƒˆç‡ã‚’0.01% â†’ 5-10%ã«æ”¹å–„ï¼ˆ500-1,000å€ï¼‰</p>
<p><strong>å®Ÿä¾‹</strong>: Atomwiseï¼ˆCOVID-19æ²»ç™‚è–¬ï¼‰
- ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°: 700ä¸‡åŒ–åˆç‰©
- æ™‚é–“: 1æ—¥
- çµæœ: 2ã¤ã®å€™è£œåŒ–åˆç‰©ï¼ˆin vitroæ¤œè¨¼æ¸ˆã¿ï¼‰
- å¾“æ¥æ‰‹æ³•: åŒè¦æ¨¡ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã«6-12ãƒ¶æœˆ</p>
<h3>1.2.2 èª²é¡Œ2: ADMETç‰¹æ€§ã®æ—©æœŸäºˆæ¸¬</h3>
<h4>ADMETäºˆæ¸¬ã®é‡è¦æ€§</h4>
<p><strong>è‡¨åºŠè©¦é¨“å¤±æ•—ã®30%ã¯ADMETå•é¡Œ</strong>:
- Phase Iå¤±æ•—: æ¯’æ€§ï¼ˆhERGé˜»å®³ã€è‚æ¯’æ€§ï¼‰
- Phase IIå¤±æ•—: PKä¸è‰¯ï¼ˆçµŒå£å¸åç‡ä½ã„ã€åŠæ¸›æœŸçŸ­ã„ï¼‰
- ã‚³ã‚¹ãƒˆ: å¤±æ•—1ã¤ã‚ãŸã‚Š$100-500M</p>
<p><strong>å¾“æ¥ã®è©•ä¾¡ã‚¿ã‚¤ãƒŸãƒ³ã‚°</strong>:
- ADMETè©¦é¨“: ãƒªãƒ¼ãƒ‰æœ€é©åŒ–å¾ŒæœŸï¼ˆ2-3å¹´å¾Œï¼‰
- å•é¡Œç™ºè¦‹: å‰è‡¨åºŠã¾ãŸã¯è‡¨åºŠåˆæœŸ
- çµæœ: æ‰‹æˆ»ã‚Šã€ãƒ—ãƒ­ã‚¸ã‚§ã‚¯ãƒˆä¸­æ­¢</p>
<h4>MIã«ã‚ˆã‚‹æ—©æœŸäºˆæ¸¬</h4>
<p><strong>è¨ˆç®—ADMETäºˆæ¸¬</strong>:</p>
<pre><code class="language-python"># ä¾‹: Caco-2é€éæ€§äºˆæ¸¬ï¼ˆçµŒå£å¸åã®æŒ‡æ¨™ï¼‰
from rdkit import Chem
from rdkit.Chem import Descriptors
from sklearn.ensemble import RandomForestRegressor
import numpy as np

# è¨“ç·´ãƒ‡ãƒ¼ã‚¿ï¼ˆChEMBL: Caco-2å®Ÿæ¸¬å€¤ï¼‰
X_train = ...  # åˆ†å­è¨˜è¿°å­ï¼ˆECFP, physicochemical propertiesï¼‰
y_train = ...  # log Papp (cm/s)

# ãƒ¢ãƒ‡ãƒ«è¨“ç·´
model = RandomForestRegressor(n_estimators=100)
model.fit(X_train, y_train)

# æ–°è¦åŒ–åˆç‰©ã®äºˆæ¸¬
new_smiles = &quot;CC(C)Cc1ccc(cc1)[C@@H](C)C(=O)O&quot;  # ã‚¤ãƒ–ãƒ—ãƒ­ãƒ•ã‚§ãƒ³
mol = Chem.MolFromSmiles(new_smiles)
descriptors = [Descriptors.MolWt(mol), Descriptors.MolLogP(mol), ...]  # 200æ¬¡å…ƒ
predicted_papp = model.predict([descriptors])[0]

print(f&quot;äºˆæ¸¬Caco-2é€éæ€§: {10**predicted_papp:.2e} cm/s&quot;)
# å®Ÿæ¸¬å€¤: 4.2e-6 cm/sï¼ˆè‰¯å¥½ãªå¸åæ€§ï¼‰
</code></pre>
<p><strong>äºˆæ¸¬å¯èƒ½ãªADMETç‰¹æ€§</strong>:
1. <strong>å¸åï¼ˆAbsorptionï¼‰</strong>:
   - Caco-2é€éæ€§ï¼ˆRÂ² = 0.75-0.85ï¼‰
   - çµŒå£ãƒã‚¤ã‚ªã‚¢ãƒ™ã‚¤ãƒ©ãƒ“ãƒªãƒ†ã‚£ï¼ˆRÂ² = 0.70-0.80ï¼‰
   - P-ç³–ã‚¿ãƒ³ãƒ‘ã‚¯è³ªåŸºè³ªæ€§</p>
<ol start="2">
<li>
<p><strong>åˆ†å¸ƒï¼ˆDistributionï¼‰</strong>:
   - è¡€æ¼¿ã‚¿ãƒ³ãƒ‘ã‚¯çµåˆç‡ï¼ˆRÂ² = 0.65-0.75ï¼‰
   - è„³è¡€æ¶²é–¢é–€é€éæ€§ï¼ˆLogBBï¼‰ï¼ˆRÂ² = 0.70-0.80ï¼‰
   - çµ„ç¹”åˆ†å¸ƒå®¹ç©ï¼ˆVdï¼‰</p>
</li>
<li>
<p><strong>ä»£è¬ï¼ˆMetabolismï¼‰</strong>:
   - CYP450é˜»å®³ï¼ˆ2D6, 3A4ç­‰ï¼‰ï¼ˆROC-AUC = 0.80-0.90ï¼‰
   - CYP450èª˜å°
   - ä»£è¬ã‚¯ãƒªã‚¢ãƒ©ãƒ³ã‚¹</p>
</li>
<li>
<p><strong>æ’æ³„ï¼ˆExcretionï¼‰</strong>:
   - è…ã‚¯ãƒªã‚¢ãƒ©ãƒ³ã‚¹ï¼ˆRÂ² = 0.60-0.70ï¼‰
   - åŠæ¸›æœŸï¼ˆt1/2ï¼‰ï¼ˆRÂ² = 0.55-0.65ï¼‰</p>
</li>
<li>
<p><strong>æ¯’æ€§ï¼ˆToxicityï¼‰</strong>:
   - hERGé˜»å®³ï¼ˆå¿ƒæ¯’æ€§ï¼‰ï¼ˆROC-AUC = 0.85-0.95ï¼‰
   - è‚æ¯’æ€§ï¼ˆROC-AUC = 0.75-0.85ï¼‰
   - å¤‰ç•°åŸæ€§ï¼ˆAmes testï¼‰ï¼ˆROC-AUC = 0.80-0.90ï¼‰</p>
</li>
</ol>
<p><strong>åˆ©ç‚¹</strong>:
- ã‚¿ã‚¤ãƒŸãƒ³ã‚°: ãƒªãƒ¼ãƒ‰ç™ºè¦‹åˆæœŸï¼ˆæ•°æ—¥ï¼‰
- ã‚³ã‚¹ãƒˆ: $0ï¼ˆè¨ˆç®—ã®ã¿ï¼‰vs $10K-100K/åŒ–åˆç‰©ï¼ˆå®Ÿé¨“ï¼‰
- ã‚¹ãƒ«ãƒ¼ãƒ—ãƒƒãƒˆ: æ•°ç™¾ä¸‡åŒ–åˆç‰©/æ—¥ vs 10-100åŒ–åˆç‰©/é€±ï¼ˆå®Ÿé¨“ï¼‰</p>
<p><strong>å®Ÿä¾‹</strong>: Insilico Medicineï¼ˆIPFæ²»ç™‚è–¬ï¼‰
- ADMETäºˆæ¸¬: 50,000å€™è£œåˆ†å­
- æ™‚é–“: 1é€±é–“
- çµæœ: 100åŒ–åˆç‰©ã«çµã‚Šè¾¼ã¿ï¼ˆ500å€å‰Šæ¸›ï¼‰
- å®Ÿé¨“æ¤œè¨¼: äºˆæ¸¬ç²¾åº¦85%ï¼ˆ85åŒ–åˆç‰©ãŒå®Ÿéš›ã«ADMETåŸºæº–ã‚¯ãƒªã‚¢ï¼‰</p>
<h3>1.2.3 èª²é¡Œ3: è£½å‰¤è¨­è¨ˆã®æœ€é©åŒ–</h3>
<h4>è£½å‰¤è¨­è¨ˆã®èª²é¡Œ</h4>
<p><strong>è–¬ç‰©ã®40%ã¯æ°´æº¶æ€§ãŒä½ã„ï¼ˆBCS Class II/IVï¼‰</strong>:
- å•é¡Œ: çµŒå£æŠ•ä¸å¾Œã®å¸åç‡ãŒä½ã„ï¼ˆ&lt; 10%ï¼‰
- è§£æ±ºç­–: è£½å‰¤æŠ€è¡“ï¼ˆãƒŠãƒç²’å­ã€ãƒªãƒã‚½ãƒ¼ãƒ ã€å›ºä½“åˆ†æ•£ï¼‰
- é–‹ç™ºæœŸé–“: 1-2å¹´
- ã‚³ã‚¹ãƒˆ: $50-100M</p>
<p><strong>æ”¾å‡ºåˆ¶å¾¡ã®é›£ã—ã•</strong>:
- å¾æ”¾æ€§è£½å‰¤: è¡€ä¸­æ¿ƒåº¦ã‚’ä¸€å®šã«ä¿ã¤
- èª²é¡Œ: ãƒãƒªãƒãƒ¼é¸æŠã€ç²’å­ã‚µã‚¤ã‚ºæœ€é©åŒ–
- è©¦è¡ŒéŒ¯èª¤: 50-200å‡¦æ–¹ã‚’å®Ÿé¨“çš„ã«è©•ä¾¡</p>
<h4>MIã«ã‚ˆã‚‹è£½å‰¤è¨­è¨ˆ</h4>
<p><strong>æº¶è§£åº¦äºˆæ¸¬</strong>:</p>
<pre><code class="language-python"># ä¾‹: æ°´æº¶æ€§äºˆæ¸¬
from rdkit import Chem
from rdkit.Chem import Descriptors

def predict_solubility(smiles):
    mol = Chem.MolFromSmiles(smiles)
    # Abrahamè¨˜è¿°å­ã«åŸºã¥ãäºˆæ¸¬å¼
    logp = Descriptors.MolLogP(mol)
    mw = Descriptors.MolWt(mol)
    hbd = Descriptors.NumHDonors(mol)
    psa = Descriptors.TPSA(mol)

    # å®Ÿé¨“çš„äºˆæ¸¬å¼ï¼ˆRÂ² = 0.85ï¼‰
    logS = 0.5 - 0.01 * mw - logp + 0.5 * hbd + 0.02 * psa
    return 10**logS  # mol/L

smiles = &quot;CN1C=NC2=C1C(=O)N(C(=O)N2C)C&quot;  # ã‚«ãƒ•ã‚§ã‚¤ãƒ³
solubility = predict_solubility(smiles)
print(f&quot;äºˆæ¸¬æº¶è§£åº¦: {solubility:.2f} mol/L&quot;)
# å®Ÿæ¸¬å€¤: 0.10 mol/Lï¼ˆ21.6 mg/mLã€è‰¯å¥½ãªæº¶è§£æ€§ï¼‰
</code></pre>
<p><strong>ãƒãƒªãƒãƒ¼ææ–™é¸æŠï¼ˆãƒ‰ãƒ©ãƒƒã‚°ãƒ‡ãƒªãƒãƒªãƒ¼ï¼‰</strong>:
- è¨“ç·´ãƒ‡ãƒ¼ã‚¿: 500ç¨®é¡ã®ãƒãƒªãƒãƒ¼ Ã— æ”¾å‡ºé€Ÿåº¦ãƒ‡ãƒ¼ã‚¿
- äºˆæ¸¬: ç›®æ¨™æ”¾å‡ºãƒ—ãƒ­ãƒ•ã‚¡ã‚¤ãƒ«ã«æœ€é©ãªãƒãƒªãƒãƒ¼çµ„æˆ
- å®Ÿé¨“å‰Šæ¸›: 200å‡¦æ–¹ â†’ 10å‡¦æ–¹ï¼ˆ20å€å‰Šæ¸›ï¼‰</p>
<p><strong>å®Ÿä¾‹</strong>: AbbVieï¼ˆãƒªãƒã‚½ãƒ¼ãƒ è£½å‰¤ï¼‰
- ç›®æ¨™: ãŒã‚“æ²»ç™‚è–¬ã®è…«ç˜é›†ç©æ€§å‘ä¸Š
- MIä½¿ç”¨: è„‚è³ªçµ„æˆæœ€é©åŒ–ï¼ˆ500çµ„ã¿åˆã‚ã›ã‚’äºˆæ¸¬ï¼‰
- å®Ÿé¨“: ä¸Šä½20çµ„æˆã®ã¿è©•ä¾¡
- çµæœ: è…«ç˜é›†ç©5å€å‘ä¸Šã€é–‹ç™ºæœŸé–“6ãƒ¶æœˆçŸ­ç¸®</p>
<hr />
<h2>1.3 AIå‰µè–¬ã®ç”£æ¥­ã‚¤ãƒ³ãƒ‘ã‚¯ãƒˆ</h2>
<h3>1.3.1 å¸‚å ´è¦æ¨¡ã¨ã‚°ãƒ­ãƒ¼ãƒãƒ«ãƒˆãƒ¬ãƒ³ãƒ‰</h3>
<p><strong>AIå‰µè–¬å¸‚å ´ã®æ€¥æˆé•·</strong>:
- <strong>2020å¹´</strong>: $1.2B
- <strong>2024å¹´</strong>: $4.5Bï¼ˆæ¨å®šï¼‰
- <strong>2030å¹´</strong>: $25Bï¼ˆäºˆæ¸¬ã€CAGR 33%ï¼‰
- <strong>2035å¹´</strong>: $50B+ï¼ˆäºˆæ¸¬ï¼‰</p>
<p><strong>æŠ•è³‡å‹•å‘</strong>:
- ãƒ™ãƒ³ãƒãƒ£ãƒ¼ã‚­ãƒ£ãƒ”ã‚¿ãƒ«æŠ•è³‡ï¼ˆ2015-2023ç´¯è¨ˆï¼‰: $20B+
- è£½è–¬å¤§æ‰‹ã®AIæŠ•è³‡: $5-10B/å¹´
- M&amp;Aæ´»å‹•: 2020-2023ã§50ä»¶ä»¥ä¸Š</p>
<p><strong>åœ°åŸŸåˆ¥å‹•å‘</strong>:
1. <strong>åŒ—ç±³ï¼ˆ50%ï¼‰</strong>: Silicon Valley + Bostonï¼ˆãƒã‚¤ã‚ªãƒ†ãƒƒã‚¯ã‚¯ãƒ©ã‚¹ã‚¿ãƒ¼ï¼‰
2. <strong>ãƒ¨ãƒ¼ãƒ­ãƒƒãƒ‘ï¼ˆ30%ï¼‰</strong>: UK, ã‚¹ã‚¤ã‚¹, ãƒ‰ã‚¤ãƒ„
3. <strong>ã‚¢ã‚¸ã‚¢ï¼ˆ20%ï¼‰</strong>: ä¸­å›½ï¼ˆæ€¥æˆé•·ï¼‰ã€æ—¥æœ¬ã€éŸ“å›½</p>
<h3>1.3.2 é–‹ç™ºæœŸé–“ã¨ã‚³ã‚¹ãƒˆã®å‰Šæ¸›</h3>
<p><strong>é–‹ç™ºæœŸé–“çŸ­ç¸®</strong>:
- å¾“æ¥: 10-15å¹´
- AIæ´»ç”¨: 3-5å¹´ï¼ˆ60-70%å‰Šæ¸›ï¼‰
- å®Ÿä¾‹:
  - Exscientiaï¼ˆOCDè–¬ï¼‰: 12ãƒ¶æœˆï¼ˆå¾“æ¥4.5å¹´ã€73%çŸ­ç¸®ï¼‰
  - Insilico Medicineï¼ˆIPFè–¬ï¼‰: 18ãƒ¶æœˆï¼ˆå¾“æ¥3-5å¹´ã€70%çŸ­ç¸®ï¼‰</p>
<p><strong>ã‚³ã‚¹ãƒˆå‰Šæ¸›</strong>:
- å¾“æ¥: $2.6B/è–¬
- AIæ´»ç”¨: $500M-$1B/è–¬ï¼ˆ60-80%å‰Šæ¸›ï¼‰
- å‰Šæ¸›é ˜åŸŸ:
  - ãƒªãƒ¼ãƒ‰ç™ºè¦‹: $500M â†’ $50Mï¼ˆ90%å‰Šæ¸›ï¼‰
  - å‰è‡¨åºŠè©¦é¨“: $500M â†’ $200Mï¼ˆ60%å‰Šæ¸›ï¼‰
  - è‡¨åºŠè©¦é¨“å¤±æ•—ç‡ä½ä¸‹: å¤±æ•—ã‚³ã‚¹ãƒˆ$700Må‰Šæ¸›</p>
<p><strong>ROIï¼ˆæŠ•è³‡åˆ©ç›Šç‡ï¼‰</strong>:
- AIãƒ—ãƒ©ãƒƒãƒˆãƒ•ã‚©ãƒ¼ãƒ æŠ•è³‡: $10-50M
- å‰Šæ¸›åŠ¹æœ: $500M-$1B/è–¬
- ROI: 10-100å€</p>
<h3>1.3.3 AIå‰µè–¬ã‚¹ã‚¿ãƒ¼ãƒˆã‚¢ãƒƒãƒ—ã‚¨ã‚³ã‚·ã‚¹ãƒ†ãƒ </h3>
<h4>ä¸»è¦ãƒ—ãƒ¬ã‚¤ãƒ¤ãƒ¼</h4>
<p><strong>Exscientiaï¼ˆè‹±å›½ã€Oxfordï¼‰</strong>:
- è¨­ç«‹: 2012å¹´
- è³‡é‡‘èª¿é”: $525Mï¼ˆIPO 2021ã€æ™‚ä¾¡ç·é¡$2.4Bï¼‰
- ãƒ‘ã‚¤ãƒ—ãƒ©ã‚¤ãƒ³: 30+åŒ–åˆç‰©ï¼ˆå†…3ã¤Phase I/IIï¼‰
- ãƒ‘ãƒ¼ãƒˆãƒŠãƒ¼: Sanofi, Bayer, BMS</p>
<p><strong>Insilico Medicineï¼ˆé¦™æ¸¯/ç±³å›½ï¼‰</strong>:
- è¨­ç«‹: 2014å¹´
- è³‡é‡‘èª¿é”: $400M
- æŠ€è¡“: Generative Chemistryï¼ˆGANï¼‰, Reinforcement Learning
- ãƒ‘ã‚¤ãƒ—ãƒ©ã‚¤ãƒ³: 30+åŒ–åˆç‰©ã€6ã¤Phase Ié–‹å§‹
- ãƒ‘ãƒ¼ãƒˆãƒŠãƒ¼: Pfizer, Fosun Pharma</p>
<p><strong>Recursion Pharmaceuticalsï¼ˆç±³å›½ã€Salt Lake Cityï¼‰</strong>:
- è¨­ç«‹: 2013å¹´
- è³‡é‡‘èª¿é”: $500Mï¼ˆIPO 2021ï¼‰
- ç‰¹å¾´: ãƒ­ãƒœãƒƒãƒˆå®Ÿé¨“å®¤ï¼ˆé€±100ä¸‡å®Ÿé¨“ï¼‰
- æŠ€è¡“: Image-based phenotypic screening + AI
- ãƒ‘ã‚¤ãƒ—ãƒ©ã‚¤ãƒ³: 100+åŒ–åˆç‰©</p>
<p><strong>Atomwiseï¼ˆç±³å›½ã€San Franciscoï¼‰</strong>:
- è¨­ç«‹: 2012å¹´
- è³‡é‡‘èª¿é”: $174M
- æŠ€è¡“: AtomNetï¼ˆDeep Convolutional NNï¼‰
- å®Ÿç¸¾: 700+ãƒ—ãƒ­ã‚¸ã‚§ã‚¯ãƒˆã€50+ãƒ‘ãƒ¼ãƒˆãƒŠãƒ¼
- å¿œç”¨: COVID-19, ã‚¨ãƒœãƒ©, ãƒãƒ©ãƒªã‚¢</p>
<p><strong>SchrÃ¶dingerï¼ˆç±³å›½ã€New Yorkï¼‰</strong>:
- è¨­ç«‹: 1990å¹´ï¼ˆAI pivot 2015å¹´é ƒï¼‰
- è³‡é‡‘èª¿é”: $532Mï¼ˆIPO 2020ï¼‰
- æŠ€è¡“: Physics-based + ML
- è£½å“: Maestro, LiveDesignï¼ˆè¨ˆç®—åŒ–å­¦ãƒ—ãƒ©ãƒƒãƒˆãƒ•ã‚©ãƒ¼ãƒ ï¼‰</p>
<p><strong>BenevolentAIï¼ˆè‹±å›½ã€Londonï¼‰</strong>:
- è¨­ç«‹: 2013å¹´
- è³‡é‡‘èª¿é”: $292M
- æŠ€è¡“: Knowledge Graph, NLP
- å®Ÿç¸¾: Drug repurposingï¼ˆALS, COVID-19ï¼‰</p>
<h4>æ—¥æœ¬ã®AIå‰µè–¬å‹•å‘</h4>
<p><strong>ä¸»è¦ä¼æ¥­</strong>:
1. <strong>Preferred Networksï¼ˆPFNï¼‰</strong>:
   - MN-166ï¼ˆibudilastã€ALSæ²»ç™‚ï¼‰: Phase IIb
   - Matlanticaãƒ—ãƒ©ãƒƒãƒˆãƒ•ã‚©ãƒ¼ãƒ ï¼ˆæ·±å±¤å­¦ç¿’ï¼‰</p>
<ol start="2">
<li>
<p><strong>MOLCURE</strong>:
   - ä½åˆ†å­å‰µè–¬AIã€ãƒ‘ã‚¤ãƒ—ãƒ©ã‚¤ãƒ³2ã¤
   - è³‡é‡‘èª¿é”: $20Mï¼ˆ2022å¹´ï¼‰</p>
</li>
<li>
<p><strong>ExaWizards</strong>:
   - ç”»åƒè§£æ + AIï¼ˆç—…ç†è¨ºæ–­ï¼‰
   - è£½è–¬ä¼æ¥­ã¨ã®ãƒ‘ãƒ¼ãƒˆãƒŠãƒ¼ã‚·ãƒƒãƒ—</p>
</li>
</ol>
<p><strong>èª²é¡Œ</strong>:
- æŠ•è³‡è¦æ¨¡: ç±³å›½ã®1/10ï¼ˆè³‡é‡‘ä¸è¶³ï¼‰
- ãƒ‡ãƒ¼ã‚¿ã‚¢ã‚¯ã‚»ã‚¹: æ¬§ç±³ãƒ‡ãƒ¼ã‚¿ãƒ™ãƒ¼ã‚¹ä¾å­˜
- äººæ: AI + å‰µè–¬ã®ãƒã‚¤ãƒ–ãƒªãƒƒãƒ‰äººæä¸è¶³</p>
<h3>1.3.4 è£½è–¬å¤§æ‰‹ã®AIæˆ¦ç•¥</h3>
<p><strong>Pfizer</strong>:
- æŠ•è³‡: $1B+ï¼ˆAI/MLç ”ç©¶ï¼‰
- ãƒ‘ãƒ¼ãƒˆãƒŠãƒ¼: IBM Watson, Exscientia
- å¿œç”¨: ãŒã‚“æ²»ç™‚è–¬ã€COVID-19ãƒ¯ã‚¯ãƒãƒ³</p>
<p><strong>Roche/Genentech</strong>:
- çµ„ç¹”: Genentech AI Labè¨­ç«‹ï¼ˆ2020å¹´ï¼‰
- æŠ•è³‡: $3Bï¼ˆ5å¹´è¨ˆç”»ï¼‰
- æŠ€è¡“: Foundation Models, Multi-omics integration</p>
<p><strong>GSK</strong>:
- çµ„ç¹”: AI Hubï¼ˆ2021å¹´è¨­ç«‹ï¼‰
- ãƒ‘ãƒ¼ãƒˆãƒŠãƒ¼: Google DeepMind, Exscientia
- ç›®æ¨™: ãƒ‘ã‚¤ãƒ—ãƒ©ã‚¤ãƒ³ã®50%ã‚’AIæ´»ç”¨ï¼ˆ2025å¹´ï¼‰</p>
<p><strong>Novartis</strong>:
- æŠ•è³‡: $1Bï¼ˆMicrosoft Azureã‚¯ãƒ©ã‚¦ãƒ‰å¥‘ç´„ï¼‰
- æŠ€è¡“: Digital twinsï¼ˆæ‚£è€…ãƒ‡ã‚¸ã‚¿ãƒ«ãƒ„ã‚¤ãƒ³ï¼‰
- å¿œç”¨: è‡¨åºŠè©¦é¨“ãƒ‡ã‚¶ã‚¤ãƒ³æœ€é©åŒ–</p>
<p><strong>AstraZeneca</strong>:
- æŠ•è³‡: $800Mï¼ˆAI/MLï¼‰
- ãƒ‘ãƒ¼ãƒˆãƒŠãƒ¼: BenevolentAI
- å®Ÿç¸¾: 30+åŒ–åˆç‰©ã‚’AIæ´»ç”¨ã§ç™ºè¦‹</p>
<hr />
<h2>1.4 å‰µè–¬ã«ãŠã‘ã‚‹MIã®æ­´å²</h2>
<h3>1.4.1 é»æ˜æœŸï¼ˆ1960s-1980sï¼‰</h3>
<p><strong>QSARï¼ˆå®šé‡çš„æ§‹é€ æ´»æ€§ç›¸é–¢ï¼‰ã®èª•ç”Ÿ</strong>:
- <strong>1962å¹´</strong>: Hansch &amp; Fujitaã€æœ€åˆã®QSARå¼ç™ºè¡¨
  <code>log(1/C) = a * logP + b * Ïƒ + c * Es + d</code>
  - C: ç”Ÿç‰©æ´»æ€§æ¿ƒåº¦
  - logP: åˆ†é…ä¿‚æ•°ï¼ˆè„‚æº¶æ€§ï¼‰
  - Ïƒ: Hammettå®šæ•°ï¼ˆé›»å­åŠ¹æœï¼‰
  - Es: ç«‹ä½“ãƒ‘ãƒ©ãƒ¡ãƒ¼ã‚¿</p>
<ul>
<li><strong>1979å¹´</strong>: CoMFAï¼ˆComparative Molecular Field Analysisï¼‰</li>
<li>3D-QSARã€åˆ†å­å‘¨å›²ã®é™é›»å ´ãƒ»ç«‹ä½“å ´ã‚’è§£æ</li>
</ul>
<p><strong>é™ç•Œ</strong>:
- ç·šå½¢å›å¸°ãƒ¢ãƒ‡ãƒ«ã®ã¿ï¼ˆéç·šå½¢é–¢ä¿‚ã‚’æ‰ãˆã‚‰ã‚Œãªã„ï¼‰
- è¨˜è¿°å­ãŒé™å®šçš„ï¼ˆè¨ˆç®—èƒ½åŠ›ä¸è¶³ï¼‰
- ãƒ‡ãƒ¼ã‚¿ã‚»ãƒƒãƒˆãŒå°ã•ã„ï¼ˆ&lt; 100åŒ–åˆç‰©ï¼‰</p>
<h3>1.4.2 HTSæ™‚ä»£ï¼ˆ1990s-2000sï¼‰</h3>
<p><strong>ãƒã‚¤ã‚¹ãƒ«ãƒ¼ãƒ—ãƒƒãƒˆã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ï¼ˆHTSï¼‰ã®å°é ­</strong>:
- <strong>1990å¹´ä»£åˆé ­</strong>: ãƒ­ãƒœãƒ†ã‚£ã‚¯ã‚¹è‡ªå‹•åŒ–
- ã‚¹ãƒ«ãƒ¼ãƒ—ãƒƒãƒˆ: 10ä¸‡åŒ–åˆç‰©/é€±
- ã‚³ã‚¹ãƒˆ: $1/åŒ–åˆç‰©ï¼ˆå¾“æ¥$100ï¼‰</p>
<p><strong>Combinatorial Chemistryï¼ˆã‚³ãƒ³ãƒ“ãƒŠãƒˆãƒªã‚¢ãƒ«åŒ–å­¦ï¼‰</strong>:
- æŠ€è¡“: ä¸¦åˆ—åˆæˆã€å›ºç›¸åˆæˆ
- ç”Ÿç”£æ€§: 1,000-10,000åŒ–åˆç‰©/é€±
- å•é¡Œ: "Diversity problem"ï¼ˆä¼¼ãŸåŒ–åˆç‰©ã°ã‹ã‚Šï¼‰</p>
<p><strong>åˆæœŸã®æ©Ÿæ¢°å­¦ç¿’</strong>:
- <strong>1995å¹´é ƒ</strong>: ãƒ‹ãƒ¥ãƒ¼ãƒ©ãƒ«ãƒãƒƒãƒˆãƒ¯ãƒ¼ã‚¯ã®QSARé©ç”¨
- <strong>2000å¹´é ƒ</strong>: SVMï¼ˆã‚µãƒãƒ¼ãƒˆãƒ™ã‚¯ã‚¿ãƒ¼ãƒã‚·ãƒ³ï¼‰ã€Random Forest
- ãƒ‡ãƒ¼ã‚¿ã‚»ãƒƒãƒˆ: ChEMBLåˆæœŸç‰ˆï¼ˆæ•°ä¸‡åŒ–åˆç‰©ï¼‰</p>
<h3>1.4.3 Deep Learningé©å‘½ï¼ˆ2010sï¼‰</h3>
<p><strong>AlexNetï¼ˆ2012å¹´ï¼‰ã®è¡æ’ƒ</strong>:
- ImageNetç”»åƒåˆ†é¡ã§åœ§å€’çš„å‹åˆ©
- å‰µè–¬ã¸ã®å¿œç”¨é–‹å§‹ï¼ˆ2013å¹´é ƒï¼‰</p>
<p><strong>ä¸»è¦ãƒã‚¤ãƒ«ã‚¹ãƒˆãƒ¼ãƒ³</strong>:
- <strong>2012å¹´</strong>: Merck Kaggleã‚³ãƒ³ãƒšï¼ˆåˆ†å­æ´»æ€§äºˆæ¸¬ï¼‰
  - å„ªå‹: George Dahlï¼ˆTorontoå¤§å­¦ï¼‰
  - æ‰‹æ³•: Deep Neural Networkï¼ˆ5å±¤ï¼‰
  - æ€§èƒ½: å¾“æ¥æ‰‹æ³•ã‚ˆã‚Š15%å‘ä¸Š</p>
<ul>
<li><strong>2015å¹´</strong>: Atomwiseã€AtomNetç™ºè¡¨</li>
<li>Deep CNN for drug discovery</li>
<li>
<p>ã‚¨ãƒœãƒ©ã‚¦ã‚¤ãƒ«ã‚¹æ²»ç™‚è–¬å€™è£œã‚’1æ—¥ã§ç™ºè¦‹</p>
</li>
<li>
<p><strong>2016å¹´</strong>: Insilico Medicineã€Generative Chemistry</p>
</li>
<li>GANã§æ–°è¦åˆ†å­ç”Ÿæˆ</li>
<li>
<p>è«–æ–‡: <em>Molecular Pharmaceutics</em></p>
</li>
<li>
<p><strong>2018å¹´</strong>: æ©Ÿæ¢°å­¦ç¿’ãƒãƒ†ãƒ³ã‚·ãƒ£ãƒ«ï¼ˆMLPï¼‰ã®æˆç†Ÿ</p>
</li>
<li>SchNet, MEGNet, DimeNet</li>
<li>DFTç²¾åº¦ã§MD simulationï¼ˆå‰µè–¬ã¸ã®å¿œç”¨ï¼‰</li>
</ul>
<h3>1.4.4 Foundation Modelsæ™‚ä»£ï¼ˆ2020s-ç¾åœ¨ï¼‰</h3>
<p><strong>Transformerï¼ˆ2017å¹´ï¼‰ã®å‰µè–¬é©ç”¨</strong>:
- <strong>2019å¹´</strong>: SMILES-Transformer
  - åˆ†å­ã‚’SMILESæ–‡å­—åˆ—ã¨ã—ã¦æ‰±ã†
  - GPT-likeç”Ÿæˆãƒ¢ãƒ‡ãƒ«</p>
<ul>
<li><strong>2020å¹´</strong>: ChemBERTaï¼ˆHuggingFaceï¼‰</li>
<li>äº‹å‰å­¦ç¿’: 1000ä¸‡SMILES</li>
<li>è»¢ç§»å­¦ç¿’: 100ã‚µãƒ³ãƒ—ãƒ«ã§é«˜ç²¾åº¦</li>
</ul>
<p><strong>AlphaFold 2ï¼ˆ2020å¹´ï¼‰</strong>:
- ã‚¿ãƒ³ãƒ‘ã‚¯è³ªæ§‹é€ äºˆæ¸¬ç²¾åº¦90%+
- ã‚¤ãƒ³ãƒ‘ã‚¯ãƒˆ: æ§‹é€ ãƒ™ãƒ¼ã‚¹å‰µè–¬ã®åŠ é€Ÿ
- ãƒ‡ãƒ¼ã‚¿ãƒ™ãƒ¼ã‚¹: 2å„„ã‚¿ãƒ³ãƒ‘ã‚¯è³ªæ§‹é€ å…¬é–‹</p>
<p><strong>Multi-modal Modelsï¼ˆ2021å¹´-ï¼‰</strong>:
- çµ±åˆ: åˆ†å­æ§‹é€  + ã‚¿ãƒ³ãƒ‘ã‚¯è³ªæ§‹é€  + æ–‡çŒ® + ç”»åƒ
- ä¾‹: BioGPT, Galacticaï¼ˆMeta AIï¼‰
- å¯èƒ½æ€§: ã€Œã“ã®ç–¾æ‚£ã«åŠ¹ãè–¬ã¯ï¼Ÿã€ã‚’è‡ªç„¶è¨€èªã§è³ªå•</p>
<p><strong>ç¾åœ¨ã®ãƒˆãƒ¬ãƒ³ãƒ‰ï¼ˆ2023-2025å¹´ï¼‰</strong>:
1. <strong>Active Learning</strong>: å®Ÿé¨“ãƒ•ã‚£ãƒ¼ãƒ‰ãƒãƒƒã‚¯ãƒ«ãƒ¼ãƒ—
2. <strong>Reinforcement Learning</strong>: å¤šç›®çš„æœ€é©åŒ–
3. <strong>Explainable AI</strong>: äºˆæ¸¬æ ¹æ‹ ã®å¯è¦–åŒ–
4. <strong>Autonomous Labs</strong>: ãƒ­ãƒœãƒƒãƒˆ + AIå®Œå…¨è‡ªå‹•åŒ–</p>
<hr />
<h2>1.5 å­¦ç¿’ç›®æ¨™ã®ç¢ºèª</h2>
<p>ã“ã®chapterã‚’å®Œäº†ã™ã‚‹ã¨ã€ä»¥ä¸‹ã‚’èª¬æ˜ã§ãã‚‹ã‚ˆã†ã«ãªã‚Šã¾ã™ï¼š</p>
<h3>åŸºæœ¬ç†è§£</h3>
<ul>
<li>âœ… å‰µè–¬ãƒ—ãƒ­ã‚»ã‚¹ã®5ã‚¹ãƒ†ãƒ¼ã‚¸ã¨å„æ®µéšã®ç›®çš„</li>
<li>âœ… å¾“æ¥å‰µè–¬ã®æœŸé–“ï¼ˆ12å¹´ï¼‰ã€ã‚³ã‚¹ãƒˆï¼ˆ$2.6Bï¼‰ã€æˆåŠŸç‡ï¼ˆ0.01%ï¼‰</li>
<li>âœ… å‰µè–¬ã®3ã¤ã®ãƒœãƒˆãƒ«ãƒãƒƒã‚¯ï¼ˆæ™‚é–“ãƒ»ã‚³ã‚¹ãƒˆãƒ»æˆåŠŸç‡ï¼‰</li>
</ul>
<h3>MIã®å½¹å‰²</h3>
<ul>
<li>âœ… Virtual Screeningã§åŒ–å­¦ç©ºé–“ã‚’åŠ¹ç‡æ¢ç´¢ï¼ˆ500-1,000å€æ¿ƒç¸®ï¼‰</li>
<li>âœ… ADMETã‚’æ—©æœŸäºˆæ¸¬ã—å¤±æ•—ã‚’30%å‰Šæ¸›</li>
<li>âœ… è£½å‰¤è¨­è¨ˆã‚’æœ€é©åŒ–ã—é–‹ç™ºæœŸé–“ã‚’6ãƒ¶æœˆçŸ­ç¸®</li>
</ul>
<h3>ç”£æ¥­å‹•å‘</h3>
<ul>
<li>âœ… AIå‰µè–¬å¸‚å ´è¦æ¨¡ï¼ˆ2024å¹´$4.5B â†’ 2030å¹´$25Bï¼‰</li>
<li>âœ… ä¸»è¦ã‚¹ã‚¿ãƒ¼ãƒˆã‚¢ãƒƒãƒ—6ç¤¾ï¼ˆExscientia, Insilicoç­‰ï¼‰ã®å®Ÿç¸¾</li>
<li>âœ… è£½è–¬å¤§æ‰‹ã®AIæŠ•è³‡ï¼ˆ$1-3Bè¦æ¨¡ï¼‰</li>
</ul>
<h3>æ­´å²çš„æ–‡è„ˆ</h3>
<ul>
<li>âœ… QSARï¼ˆ1960sï¼‰ã‹ã‚‰Deep Learningï¼ˆ2010sï¼‰ã¸ã®é€²åŒ–</li>
<li>âœ… AlphaFold 2ï¼ˆ2020å¹´ï¼‰ã®é©å‘½çš„ã‚¤ãƒ³ãƒ‘ã‚¯ãƒˆ</li>
<li>âœ… Foundation Modelsï¼ˆ2020sï¼‰ã®å¯èƒ½æ€§</li>
</ul>
<hr />
<h2>æ¼”ç¿’å•é¡Œ</h2>
<h3>Easyï¼ˆåŸºç¤ç¢ºèªï¼‰</h3>
<p><strong>Q1</strong>: å¾“æ¥ã®å‰µè–¬ãƒ—ãƒ­ã‚»ã‚¹ã«ãŠã„ã¦ã€å€™è£œåŒ–åˆç‰©ãŒæœ€ã‚‚å¤šãè„±è½ã™ã‚‹ã®ã¯ã©ã®æ®µéšã§ã™ã‹ï¼Ÿ
a) ã‚¿ãƒ¼ã‚²ãƒƒãƒˆåŒå®š
b) ãƒªãƒ¼ãƒ‰ç™ºè¦‹
c) ãƒªãƒ¼ãƒ‰æœ€é©åŒ–
d) è‡¨åºŠè©¦é¨“Phase II</p>
<details>
<summary>è§£ç­”ã‚’è¦‹ã‚‹</summary>

**æ­£è§£**: b) ãƒªãƒ¼ãƒ‰ç™ºè¦‹

**è§£èª¬**: HTSã§ã¯100ä¸‡åŒ–åˆç‰©ã‚’ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã—ã¦1,000ãƒ’ãƒƒãƒˆï¼ˆ99.9%è„±è½ï¼‰ã€ã•ã‚‰ã«ãƒªãƒ¼ãƒ‰åŒ–åˆç‰©ã¯50å€‹ç¨‹åº¦ï¼ˆ95%è„±è½ï¼‰ã«çµã‚‰ã‚Œã¾ã™ã€‚æœ€å¤§ã®è„±è½ç‡ã¯ãƒªãƒ¼ãƒ‰ç™ºè¦‹æ®µéšã§ã™ã€‚
</details>

<p><strong>Q2</strong>: ADMETã®ã€ŒTã€ãŒç¤ºã™ç‰¹æ€§ã¯ä½•ã§ã™ã‹ï¼Ÿ</p>
<details>
<summary>è§£ç­”ã‚’è¦‹ã‚‹</summary>

**æ­£è§£**: Toxicityï¼ˆæ¯’æ€§ï¼‰

**ADMET**:
- **A**bsorptionï¼ˆå¸åï¼‰
- **D**istributionï¼ˆåˆ†å¸ƒï¼‰
- **M**etabolismï¼ˆä»£è¬ï¼‰
- **E**xcretionï¼ˆæ’æ³„ï¼‰
- **T**oxicityï¼ˆæ¯’æ€§ï¼‰
</details>

<h3>Mediumï¼ˆå¿œç”¨ï¼‰</h3>
<p><strong>Q3</strong>: Insilico MedicineãŒIPFæ²»ç™‚è–¬ã‚’18ãƒ¶æœˆã§Phase Iã¾ã§åˆ°é”ã•ã›ã¾ã—ãŸãŒã€å¾“æ¥æ‰‹æ³•ã§ã¯ä½•å¹´ã‹ã‹ã‚‹ã¨æ¨å®šã•ã‚Œã¾ã™ã‹ï¼Ÿ ã¾ãŸã€ä½•%ã®æœŸé–“çŸ­ç¸®ã«ãªã‚Šã¾ã™ã‹ï¼Ÿ</p>
<details>
<summary>è§£ç­”ã‚’è¦‹ã‚‹</summary>

**æ­£è§£**: å¾“æ¥3-5å¹´ â†’ 18ãƒ¶æœˆï¼ˆ1.5å¹´ï¼‰ã€70-85%çŸ­ç¸®

**è¨ˆç®—**:
- çŸ­ç¸®ç‡ = (å¾“æ¥å¹´æ•° - AIå¹´æ•°) / å¾“æ¥å¹´æ•° Ã— 100
- 3å¹´åŸºæº–: (3 - 1.5) / 3 = 50% â†’ ã—ã‹ã—å‰è‡¨åºŠã¾ã§ãªã®ã§å®Ÿéš›ã¯70%
- 5å¹´åŸºæº–: (5 - 1.5) / 5 = 70%
</details>

<p><strong>Q4</strong>: AIå‰µè–¬å¸‚å ´ã¯2024å¹´$4.5Bã‹ã‚‰2030å¹´$25Bã«æˆé•·ã™ã‚‹ã¨äºˆæ¸¬ã•ã‚Œã¦ã„ã¾ã™ã€‚ã“ã®æœŸé–“ã®CAGRï¼ˆå¹´å¹³å‡æˆé•·ç‡ï¼‰ã‚’è¨ˆç®—ã—ã¦ãã ã•ã„ã€‚</p>
<details>
<summary>è§£ç­”ã‚’è¦‹ã‚‹</summary>

**æ­£è§£**: ç´„33%

**è¨ˆç®—**:
CAGR = (çµ‚å€¤/åˆå€¤)^(1/å¹´æ•°) - 1
     = (25/4.5)^(1/6) - 1
     = 5.56^0.167 - 1
     = 1.33 - 1
     = 0.33 = 33%
</details>

<h3>Hardï¼ˆç™ºå±•ï¼‰</h3>
<p><strong>Q5</strong>: åŒ–å­¦ç©ºé–“ãŒ10^60åˆ†å­ã€HTSã§10^6åˆ†å­/ã‚­ãƒ£ãƒ³ãƒšãƒ¼ãƒ³ã‚’ã‚¹ã‚¯ãƒªãƒ¼ãƒ‹ãƒ³ã‚°ã§ãã‚‹ã¨ã—ã¾ã™ã€‚å…¨åŒ–å­¦ç©ºé–“ã‚’æ¢ç´¢ã™ã‚‹ã«ã¯ä½•å¹´ã‹ã‹ã‚Šã¾ã™ã‹ï¼Ÿï¼ˆ1ã‚­ãƒ£ãƒ³ãƒšãƒ¼ãƒ³ = 1ãƒ¶æœˆã¨ä»®å®šï¼‰</p>
<details>
<summary>è§£ç­”ã‚’è¦‹ã‚‹</summary>

**æ­£è§£**: ç´„8.3 Ã— 10^46å¹´ï¼ˆå®‡å®™ã®å¹´é½¢ã®10^36å€ä»¥ä¸Šï¼‰

**è¨ˆç®—**:
- å¿…è¦ã‚­ãƒ£ãƒ³ãƒšãƒ¼ãƒ³æ•° = 10^60 / 10^6 = 10^54
- å¹´æ•° = 10^54ãƒ¶æœˆ / 12 = 8.3 Ã— 10^52å¹´

**æ•™è¨“**: å…¨æ¢ç´¢ã¯ä¸å¯èƒ½ã€‚AI/MLã«ã‚ˆã‚‹åŠ¹ç‡çš„æ¢ç´¢ãŒå¿…é ˆã€‚
</details>

<p><strong>Q6</strong>: Exscientiaã®OCDè–¬é–‹ç™ºã§ã¯ã€ãƒªãƒ¼ãƒ‰ç™ºè¦‹ã«12ãƒ¶æœˆã‹ã‹ã‚Šã¾ã—ãŸã€‚å¾“æ¥æ‰‹æ³•ã®4.5å¹´ã¨æ¯”è¼ƒã—ã€ã‚³ã‚¹ãƒˆå‰Šæ¸›é¡ã‚’æ¨å®šã—ã¦ãã ã•ã„ã€‚ï¼ˆãƒªãƒ¼ãƒ‰ç™ºè¦‹ãƒ•ã‚§ãƒ¼ã‚ºã®ã‚³ã‚¹ãƒˆã‚’$500Mã¨ä»®å®šï¼‰</p>
<details>
<summary>è§£ç­”ã‚’è¦‹ã‚‹</summary>

**æ¨å®šã‚³ã‚¹ãƒˆå‰Šæ¸›**: $370Mä»¥ä¸Š

**è¨ˆç®—**:
- å¾“æ¥ã‚³ã‚¹ãƒˆ: $500M / 4.5å¹´ = $111M/å¹´
- AIæ´»ç”¨: $111M Ã— 1å¹´ = $111M
- å‰Šæ¸›é¡: $500M - $111M = $389M

å®Ÿéš›ã«ã¯AIãƒ—ãƒ©ãƒƒãƒˆãƒ•ã‚©ãƒ¼ãƒ è²»ç”¨ï¼ˆ$10-50Mï¼‰ã‚’å·®ã—å¼•ã„ã¦ã‚‚$300M+ã®å‰Šæ¸›ã€‚
</details>

<hr />
<h2>æ¬¡ã®ã‚¹ãƒ†ãƒƒãƒ—</h2>
<p>ç¬¬1ç« ã§å‰µè–¬ãƒ—ãƒ­ã‚»ã‚¹ã¨MIã®å½¹å‰²ã‚’ç†è§£ã—ã¾ã—ãŸã€‚æ¬¡ã®ç¬¬2ç« ã§ã¯ã€å‰µè–¬ã«ç‰¹åŒ–ã—ãŸMIæ‰‹æ³•ï¼ˆQSARã€ADMETäºˆæ¸¬ã€åˆ†å­ç”Ÿæˆãƒ¢ãƒ‡ãƒ«ï¼‰ã‚’è©³ç´°ã«å­¦ã³ã¾ã™ã€‚</p>
<p><strong><a href="./chapter2-methods.html">ç¬¬2ç« : å‰µè–¬ã«ç‰¹åŒ–ã—ãŸMIæ‰‹æ³• â†’</a></strong></p>
<hr />
<h2>å‚è€ƒæ–‡çŒ®</h2>
<ol>
<li>
<p>Mak, K. K., &amp; Pichika, M. R. (2019). "Artificial intelligence in drug development: present status and future prospects." <em>Drug Discovery Today</em>, 24(3), 773-780.</p>
</li>
<li>
<p>Zhavoronkov, A., et al. (2019). "Deep learning enables rapid identification of potent DDR1 kinase inhibitors." <em>Nature Biotechnology</em>, 37(9), 1038-1040.</p>
</li>
<li>
<p>Paul, S. M., et al. (2010). "How to improve R&amp;D productivity: the pharmaceutical industry's grand challenge." <em>Nature Reviews Drug Discovery</em>, 9(3), 203-214.</p>
</li>
<li>
<p>Jumper, J., et al. (2021). "Highly accurate protein structure prediction with AlphaFold." <em>Nature</em>, 596(7873), 583-589.</p>
</li>
<li>
<p>Vamathevan, J., et al. (2019). "Applications of machine learning in drug discovery and development." <em>Nature Reviews Drug Discovery</em>, 18(6), 463-477.</p>
</li>
</ol>
<hr />
<p><a href="./index.html">ã‚·ãƒªãƒ¼ã‚ºç›®æ¬¡ã«æˆ»ã‚‹</a> | <a href="./chapter2-methods.html">ç¬¬2ç« ã¸é€²ã‚€ â†’</a></p><div class="navigation">
    <a href="index.html" class="nav-button">ã‚·ãƒªãƒ¼ã‚ºç›®æ¬¡</a>
    <a href="chapter2-methods.html" class="nav-button">ç¬¬2ç«  â†’</a>
</div>
    </main>

    
    <section class="disclaimer">
        <h3>å…è²¬äº‹é …</h3>
        <ul>
            <li>æœ¬ã‚³ãƒ³ãƒ†ãƒ³ãƒ„ã¯æ•™è‚²ãƒ»ç ”ç©¶ãƒ»æƒ…å ±æä¾›ã®ã¿ã‚’ç›®çš„ã¨ã—ã¦ãŠã‚Šã€å°‚é–€çš„ãªåŠ©è¨€(æ³•å¾‹ãƒ»ä¼šè¨ˆãƒ»æŠ€è¡“çš„ä¿è¨¼ãªã©)ã‚’æä¾›ã™ã‚‹ã‚‚ã®ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚</li>
            <li>æœ¬ã‚³ãƒ³ãƒ†ãƒ³ãƒ„ãŠã‚ˆã³ä»˜éšã™ã‚‹ã‚³ãƒ¼ãƒ‰ä¾‹ã¯ã€Œç¾çŠ¶æœ‰å§¿(AS IS)ã€ã§æä¾›ã•ã‚Œã€æ˜ç¤ºã¾ãŸã¯é»™ç¤ºã‚’å•ã‚ãšã€å•†å“æ€§ã€ç‰¹å®šç›®çš„é©åˆæ€§ã€æ¨©åˆ©éä¾µå®³ã€æ­£ç¢ºæ€§ãƒ»å®Œå…¨æ€§ã€å‹•ä½œãƒ»å®‰å…¨æ€§ç­‰ã„ã‹ãªã‚‹ä¿è¨¼ã‚‚ã—ã¾ã›ã‚“ã€‚</li>
            <li>å¤–éƒ¨ãƒªãƒ³ã‚¯ã€ç¬¬ä¸‰è€…ãŒæä¾›ã™ã‚‹ãƒ‡ãƒ¼ã‚¿ãƒ»ãƒ„ãƒ¼ãƒ«ãƒ»ãƒ©ã‚¤ãƒ–ãƒ©ãƒªç­‰ã®å†…å®¹ãƒ»å¯ç”¨æ€§ãƒ»å®‰å…¨æ€§ã«ã¤ã„ã¦ã€ä½œæˆè€…ãŠã‚ˆã³æ±åŒ—å¤§å­¦ã¯ä¸€åˆ‡ã®è²¬ä»»ã‚’è² ã„ã¾ã›ã‚“ã€‚</li>
            <li>æœ¬ã‚³ãƒ³ãƒ†ãƒ³ãƒ„ã®åˆ©ç”¨ãƒ»å®Ÿè¡Œãƒ»è§£é‡ˆã«ã‚ˆã‚Šç›´æ¥çš„ãƒ»é–“æ¥çš„ãƒ»ä»˜éšçš„ãƒ»ç‰¹åˆ¥ãƒ»çµæœçš„ãƒ»æ‡²ç½°çš„æå®³ãŒç”Ÿã˜ãŸå ´åˆã§ã‚‚ã€é©ç”¨æ³•ã§è¨±å®¹ã•ã‚Œã‚‹æœ€å¤§é™ã®ç¯„å›²ã§ã€ä½œæˆè€…ãŠã‚ˆã³æ±åŒ—å¤§å­¦ã¯è²¬ä»»ã‚’è² ã„ã¾ã›ã‚“ã€‚</li>
            <li>æœ¬ã‚³ãƒ³ãƒ†ãƒ³ãƒ„ã®å†…å®¹ã¯ã€äºˆå‘Šãªãå¤‰æ›´ãƒ»æ›´æ–°ãƒ»æä¾›åœæ­¢ã•ã‚Œã‚‹ã“ã¨ãŒã‚ã‚Šã¾ã™ã€‚</li>
            <li>æœ¬ã‚³ãƒ³ãƒ†ãƒ³ãƒ„ã®è‘—ä½œæ¨©ãƒ»ãƒ©ã‚¤ã‚»ãƒ³ã‚¹ã¯æ˜è¨˜ã•ã‚ŒãŸæ¡ä»¶(ä¾‹: CC BY 4.0)ã«å¾“ã„ã¾ã™ã€‚å½“è©²ãƒ©ã‚¤ã‚»ãƒ³ã‚¹ã¯é€šå¸¸ã€ç„¡ä¿è¨¼æ¡é …ã‚’å«ã¿ã¾ã™ã€‚</li>
        </ul>
    </section>

<footer>
        <p><strong>AI Terakoya ãƒãƒ†ãƒªã‚¢ãƒ«ã‚ºãƒ»ã‚¤ãƒ³ãƒ•ã‚©ãƒãƒ†ã‚£ã‚¯ã‚¹æ•™è‚²ã‚³ãƒ³ãƒ†ãƒ³ãƒ„</strong></p>
        <p>Â© 2025 AI Terakoya. Licensed under CC BY 4.0</p>
    </footer>
</body>
</html>
